News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VentiRx Pharmaceuticals, Inc. Appoints Kent Snyder to Board of Directors


4/16/2007 12:05:33 PM

SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel medicines for the treatment of cancer and infectious, respiratory and autoimmune diseases, announced today the appointment of Kent Snyder to its Board of Directors.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES